Effects of glucocorticoids on maxillary bone mineral density in rat model of adriamycin-induced nephropathy
10.11958/20160555
- VernacularTitle:激素治疗对阿霉素肾病大鼠上颌骨骨密度的影响
- Author:
Xiaoyan HOU
;
Xiaoying LI
;
Lele GUO
;
Ming MA
;
Yi GUO
;
Cheng PENG
- Keywords:
nephrotic syndrome;
maxilla;
bone density;
glucocorticoids;
osteoporosis;
rats,Wistar;
adriamycin-induced nephrotoxicity;
micro-CT
- From:
Tianjin Medical Journal
2016;44(12):1432-1435
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate effects of glucocorticoids on maxillary bone mineral density in rats with acute adriamycin-induced nephrotoxicity (ADR). Methods Forty rats were randomly divided into four groups, control group, glucocorticoids- treated group, ADR group and ADR + glucocorticoids- treated group. ADR group and ADR +glucocorticoids-treated group were given 4 mg/kg adriamycin injection via tail vein to establish ADR model. Control group and glucocorticoids-treated group were given 4 mg/kg saline injection via tail vein. After establishment of ADR model, glucocorticoids-treated group and ADR + glucocorticoids-treated group were intragastric administration of 30 mg/(kg · d) methylprednisolone for 10 weeks, and control group and ADR group were given the same volumes of normal saline. Values of bone calcium pigment (BGP), type Ⅰ collagen, N-terminal pro-peptide (PINP), β-Ⅰ type collagen C-terminal cross-linked telopeptide (CTX) were detected by ELISA. The micro-CT scan was used to measure Tb.Th, Tb.Sp, Tb.N, BVF and bone mineral density (BMD). Results Compared with other three groups, the levels of BGP and PINP were significantly decreased, and CTX were significantly increased in ADR + glucocorticoids-treated group (P<0.05). Micro-CT analysis showed that there was significant maxillae osteoporosis, including changes of porous micro architecture, lower BMD, decreased BVF, lower Tb.Th and widening Tb.Sp in ADR + glucocorticoids-treated group (P<0.05). There was no significant difference in Tb.N between four groups. Conclusion There is imbalanced bone metabolism in rat model of ADR. High-dose hormone therapy can accelerate the occurrence of osteoporosis, decrease bone metabolism, and affect bone structure.
